Larotin, Fe S.

HRN: 22-25-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
CEFTRIAXONE 1G (VIAL)
11/29/2022
12/05/2022
IV
2g
Q24
Bleeding And Infected & Breast Mass
Waiting Final Action 
11/29/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/29/2022
12/05/2022
IV
600mg
Q8
Bleeding & Infected Breast Mass
Waiting Final Action 
11/29/2022
CEFTAZIDIME 1GM (VIAL)
11/29/2022
12/06/2022
IV
1g
Q8
Infected Breast Mass
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: